937174-97-5Relevant academic research and scientific papers
Tetrahydroimidazo[1,5-d][1,4]oxazepine compound
-
Paragraph 0107; 0108, (2016/03/14)
A compound represented by formula (I): wherein R is a methyl group or the like, R1 is a fluorine atom or the like, R2 is a hydrogen atom or a fluorine atom, R3 is a hydrogen atom, R4 is an ethyl group or the lik
Tetrahydroimidazo(1,5-D)[1,4]Oxazepine Derivative
-
Paragraph 0220; 0221; 0222, (2014/09/03)
A compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof works as an mGluR2 antagonist, and is applicable as a therapeutic agent for neurological disorders related to glutamate dysfunction and diseases involving th
METHODS OF USE FOR INHIBITORS OF AKT ACTIVITY
-
Page/Page column 51, (2008/12/04)
Invented is the use of 1 H-imidazo[4,5-c]pyridin-2-yl compounds in the treatment of specified cancers.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 58, (2008/06/13)
Invented are novel 1 H-imidazo[4,5-c]pyridin-2-yl compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
